U.S. flag

An official website of the United States government

NM_004820.5(CYP7B1):c.1250G>A (p.Arg417His) AND Spastic paraplegia

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Dec 2, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000206595.10

Allele description [Variation Report for NM_004820.5(CYP7B1):c.1250G>A (p.Arg417His)]

NM_004820.5(CYP7B1):c.1250G>A (p.Arg417His)

Gene:
CYP7B1:cytochrome P450 family 7 subfamily B member 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
8q12.3
Genomic location:
Preferred name:
NM_004820.5(CYP7B1):c.1250G>A (p.Arg417His)
HGVS:
  • NC_000008.11:g.64596913C>T
  • NG_008338.2:g.206879G>A
  • NM_001324112.2:c.1234-7069G>A
  • NM_004820.5:c.1250G>AMANE SELECT
  • NP_004811.1:p.Arg417His
  • NC_000008.10:g.65509470C>T
  • NM_004820.3:c.1250G>A
  • NM_004820.4:c.1250G>A
  • O75881:p.Arg417His
Protein change:
R417H; ARG417HIS
Links:
UniProtKB: O75881#VAR_044385; OMIM: 603711.0004; dbSNP: rs121908611
NCBI 1000 Genomes Browser:
rs121908611
Molecular consequence:
  • NM_001324112.2:c.1234-7069G>A - intron variant - [Sequence Ontology: SO:0001627]
  • NM_004820.5:c.1250G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Spastic paraplegia
Identifiers:
MedGen: C0037772; Human Phenotype Ontology: HP:0001258

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000261512Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Dec 2, 2023)
germlineclinical testing

PubMed (6)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Sequence alterations within CYP7B1 implicate defective cholesterol homeostasis in motor-neuron degeneration.

Tsaousidou MK, Ouahchi K, Warner TT, Yang Y, Simpson MA, Laing NG, Wilkinson PA, Madrid RE, Patel H, Hentati F, Patton MA, Hentati A, Lamont PJ, Siddique T, Crosby AH.

Am J Hum Genet. 2008 Feb;82(2):510-5. doi: 10.1016/j.ajhg.2007.10.001. Epub 2008 Jan 18.

PubMed [citation]
PMID:
18252231
PMCID:
PMC2426914

CYP7B1 mutations in French-Canadian hereditary spastic paraplegia subjects.

Noreau A, Dion PA, Szuto A, Levert A, Thibodeau P, Brais B, Dupré N, Rioux MF, Rouleau GA.

Can J Neurol Sci. 2012 Jan;39(1):91-4. No abstract available.

PubMed [citation]
PMID:
22384504
See all PubMed Citations (6)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV000261512.8

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (6)

Description

This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 417 of the CYP7B1 protein (p.Arg417His). This variant is present in population databases (rs121908611, gnomAD 0.01%). This missense change has been observed in individual(s) with autosomal recessive hereditary spastic paraplegia (PMID: 18252231, 19439420, 22384504). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 6103). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt CYP7B1 protein function with a positive predictive value of 80%. This variant disrupts the p.Arg417 amino acid residue in CYP7B1. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 19439420, 21567895, 24658845). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Oct 13, 2024